Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $21.87 Analyst target: $107.29 Upside: 390.58%
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. The company is headquartered in South San Francisco, California.
See the full interactive analysis & chart →Informational only — not investment advice.